Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04210726

Effect of Salt Solution Immersion Bath on Cancer in Vivo.

Effect of Human Body Immersion in Hypertonic Saline Solution on Cancer Nodules' Size, Number and Its Metastasis Properties in Vivo.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Rafik Batroussy · Academic / Other
Sex
All
Age
5 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This Study evaluates the effectiveness of Hypertonic Saline Bath in reducing the Cancer nodules' size, number and SUVmax.

Detailed description

Many previous studies have shown that the Cancer cells are over-hydrated, and that Hyponatraemia exists in many cases of Cancer. The Cancer cell's viability depends on Angiogenesis and formation of blood vessels that carry water and nutrient to the rapidly-dividing Cancer cells. This study tests the hypothesis that disrupting the water content of blood could lead to increasing its Tonicity and hence withdrawing water from the Cancer cells by Osmosis, which can result in disrupting the growth of the Cancer cell itself. This disruption of Blood Water content can be achieved using Osmotic Pressure differential via immersing the whole body in Hypertonic Saline Solution for a certain amount of time, thus making the Blood more Hypertonic relative to the cells of the body and of the cancer, leading to water withdrawal from the cells of the body and of the cancer. While body's cells can sustain temporary dehydration, Cancer cells could be negatively affected.

Conditions

Interventions

TypeNameDescription
DRUG25% Hypertonic Saline Bath25% Sea Salt (mainly Sodium Chloride - NaCl) in Tap Water Immersion Bath (made by adding Sodium Chloride in the form of Sea Salt to Tap Water to a concentration of 25%).
OTHER0.9% Isotonic Saline Bath0.9% Sea Salt (mainly Sodium Chloride - NaCl) in Tap Water Immersion Bath (made by adding Sodium Chloride in the form of Sea Salt to Tap Water to a concentration of 0.9%).

Timeline

Start date
2020-03-01
Primary completion
2020-12-01
Completion
2021-03-01
First posted
2019-12-26
Last updated
2023-07-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04210726. Inclusion in this directory is not an endorsement.